pdf
Published
2021-11-22
Issue
Section
Pharmacy Practice & Practice-Based Research
Categories
License
Copyright (c) 2021 Michael J. Schuh, Sheena Crosby
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
Michael J. Schuh
Mayo School of Health Related Sciences
Sheena Crosby
Mayo Clinic Florida
DOI: https://doi.org/10.24926/iip.v12i4.4034
Keywords: conversion disorder, case report, pharmacogenomics, polypharmacy
Abstract
Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists.
Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD.
Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.
